Skip to content

Repotrectinib

Repotrectinib comes in 2 pill versions in our database, in 2 strengths, from 1 manufacturer. Check the imprint to tell them apart.

Repotrectinib pill images

40 mg 1 pill

160 mg 1 pill

What is Repotrectinib used for?

Repotrectinib is a cancer medicine (kinase inhibitor).

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

ROS1-Positive Non-Small Cell Lung Cancer

AUGTYRO is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).

NTRK Gene Fusion-Positive Solid Tumors

AUGTYRO is indicated for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that:

  • have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion,
  • are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity, and
  • have progressed following treatment or have no satisfactory alternative therapy.

This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

From the FDA-approved label on DailyMed (published Aug 11, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.